Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Ya. V. Gridneva"'
1
Akademický článek
Cabazitaxel in the treatment of castration-resistant cancer: hitting the balance of efficacy and safety
Autor: M. I. Volkova, Ya. V. Gridneva, A. S. Olshanskaya
Publikováno v: Медицинский совет, Vol 0, Iss 10, Pp 146-154 (2019)
Cabazitaxel, an antineoplastic agent from the third generation taxan group, has demonstrated efficacy in the treatment of metastatic castration-resistant prostate cancer (mCRPC) refractory to docetaxel. This article is devoted to a critical analysis
Externí odkaz: https://doaj.org/article/1527490782a441c1bbbc453addb0ed59
Zobrazit plný text záznamu
3
Results of combined and radiation therapy for cancer of the urethra
Autor: V. B. Matveyev, Ya. V. Gridneva
Publikováno v: Onkourologiâ, Vol 2, Iss 3, Pp 40-44 (2020)
Clinical course of primary urethral cancer is characterized in detail in 31 patients. Specific features in the disease course with consideration for tumor stage and patient's sex are analyzed. Urethral cancer is diagnosed only at stages III—IV in t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::fd2bf3bea7a177ee37427b9de228d85a
https://oncourology.abvpress.ru/oncur/article/view/1168
Zobrazit plný text záznamu
4
Urethral melanoma
Autor: Ya. V. Gridneva
Publikováno v: Onkourologiâ, Vol 1, Iss 3, Pp 66-70 (2020)
Urethral melanoma is a rare malignancy that has a poor prognosis. The paper presents the data available in the worldwide literature on urethral melanoma and analyzes the specific features of the disease occurring in males and females. It also describ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::ca49b392eec0bc29a3ab9dac9bb65df7
https://oncourology.abvpress.ru/oncur/article/view/1205
Zobrazit plný text záznamu
7
Immunotherapy in urothelial cancer: recent data and perspectives
Autor: M. I. Volkova, Ya. V. Gridneva, A. S. Ol’shanskaya
Publikováno v: Onkourologiâ, Vol 13, Iss 4, Pp 16-24 (2018)
Immune-checkpoint inhibitors blocking the programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) and cytotoxic T-lymphocyteassociated protein 4 (CTLA-4) have shown a prominent anti-tumor activity with long-term responses and an acceptable toxicity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4217ec8edac07ed34866a2b1c4fa3db1
https://oncourology.abvpress.ru/oncur/article/view/760
Zobrazit plný text záznamu
8
Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
Autor: A. S. Markova, S. B. Polikarpova, B. Sh. Kamolov, Ya. V. Gridneva, S. A. Kalinin, M. V. Peters, V. B. Matveev
Publikováno v: Onkourologiâ, Vol 11, Iss 2, Pp 77-84 (2015)
Objective: to estimate overall survival (OS) rates in patients with metastatic castration-resistant prostate cancer (mCRPC), who have received currently available drugs and to identify the predictors of OS. Subjects and methods. The case histories of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf68386fbbded51448fe808fe68b241
https://oncourology.abvpress.ru/oncur/article/view/457
Zobrazit plný text záznamu
9
SURGICAL REHABILITATION IN PATIENTS WITH ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY OR CYSTECTOMY
Autor: V. B. Matveev, Ya. V. Gridneva
Publikováno v: Onkourologiâ, Vol 6, Iss 4, Pp 65-71 (2014)
The earlier diagnosis of cancers, the improvement of a surgical technique, and advances in chemo- and hormonal therapy have increased survival rates. In this connection, some studies of quality of life have been recently under way after radical cyst-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0db5b2ecf3a32d2df4edda13c9dc356c
http://oncourology.abvpress.ru/index.php/oncur/article/view/358
Zobrazit plný text záznamu
10
LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?
Autor: V. B. Matveev, M. I. Volkova, D. Z. Kupchan, Ya. V. Gridneva
Publikováno v: Onkourologiâ, Vol 6, Iss 4, Pp 71-77 (2014)
Eligard (leupropelin acetate, Atrigel delivery system) is a synthetic analogue of luteinizing-hormone-realizing hormone (LHRH), which causes a rapid reduction in the level of testosterone to the concentration comparable with that after surgical castr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9033a185c46a5092132b04d3015ad816
https://oncourology.abvpress.ru/oncur/article/view/367
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje